Introduction: In 2019, the prevalence of dialysis in Kuwait were 465 patient/million population, while the annual mortality rate among dialysis patients reached 12%. To improve resource allocation within the health care system, a cost-effectiveness model was conducted from a societal perspective to assess the cost-effectiveness of the use of dapagliflozin as an add-on-therapy against SoC (ramipril) among CKD patients with or without type-2 diabetes over their lifetime.
Methodology: A Markov process model was utilized to assess the cost-effectiveness of dapagliflozin + ramipril versus ramipril alone on a cohort of patients with an eGFR of 25 to 75 mL/min/1.73, with or without type-2 diabetes and a urinary ACR of 200 to 5,000 over their lifetime. The model included nine health states: (i) the six stages of CKD representing stages 1, 2, 3a, 3b, 4 and 5; (ii)ESRD, which represents RRT as dialysis or kidney transplant and (iii) death. Most of the clinical data were captured from the DAPA-CKD study. We assumed that the mortality risk of our study was similar to DAPA-CKD. The utility data were captured from different studies. Direct medical and indirect costs were captured from local data sources. Sensitivity analyses were conducted.
Results: The difference in QALY between dapagliflozin + ramipril versus ramipril was 0.2. The difference in cost between the two arms was KWD -4,120 (-USD25750). Dapagliflozin + ramipril generate better QALYs and lower costs than ramipril in CKD patients. Dapagliflozin improved the outcomes and generated cost savings in CKD patients.
Conclusion: Adoption of dapagliflozin + ramipril is considered to be a cost saving option in addition to the improvement in QALYs in CKD patients with or without type-2 diabetes due to its nephroprotective effect, regardless of the aetiology of CKD, which eventually leads to reduction of dialysis and the transplantation cost burden on the Kuwaiti health care system. This study was focussed only on DAPA-CKD cohort.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1080/13696998.2023.2174749 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Plant-Based Diets Across the Spectrum of Kidney Disease.
Clin J Am Soc Nephrol
March 2025
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX.
Diet is gaining traction as a major chronic kidney disease (CKD)-related risk factor for death and disability. Furthermore, a "healthy" diet in patients with CKD is associated with reduced mortality. The data to be discussed support diet as the foundational, "food integrated with pharmacologic therapy," approach to management of individuals with CKD and those at risk for it.
View Article and Find Full Text PDFFinerenone Alleviates Over-Activation of Complement C5a-C5aR1 Axis of Macrophages by Regulating G Protein Subunit Alpha i2 to Improve Diabetic Nephropathy.
Cells
February 2025
Renal Division, Department of Medicine, Peking University First Hospital, Beijing 100034, China.
Diabetic nephropathy (DN), one of the most common complications of diabetes mellitus (DM), accounts for a major cause of chronic kidney disease (CKD) worldwide, with a complicated pathogenesis and limited effective strategies nowadays. The mineralocorticoid receptor (MR) is a classical ligand-activated nuclear transcription factor. It is expressed in the renal intrinsic and immune cells, especially macrophages.
View Article and Find Full Text PDFComorbidity-related risk factors for acute respiratory distress syndrome in sepsis patients: A systematic review and meta-analysis.
Adv Clin Exp Med
March 2025
Emergency And Intensive Care Unit, The Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
Background: Acute respiratory distress syndrome (ARDS) presents a significant challenge in the management of sepsis, with various comorbidities potentially influencing its development. Understanding the impact of these comorbidities is crucial for improving patient outcomes.
Objectives: This meta-analysis was conducted to investigate the relationship between various comorbidities and the development of ARDS in patients with sepsis, with the aim of improving understanding and management of this condition.
Prevalence of Chronic Kidney Disease Among Elderly Patients in the Northeastern Region of Romania: A Descriptive, Cross-Sectional, Retrospective Analysis.
Cureus
March 2025
Department of Medicine, University of Medicine and Pharmacy Grigore T. Popa, Iași, ROU.
In Romania, data pertaining to the incidence and prevalence of chronic kidney disease (CKD) are scant, with an even more limited understanding of the elderly demographic. In this study, we used a descriptive cross-sectional retrospective approach, drawing data from the Geriatrics and Gerontology Clinic at Dr. C.
View Article and Find Full Text PDFIllicit Drug Use and Cerebral Microbleeds in Patients with Acute Ischemic Stroke and Transient Ischemic Attack.
Int J Stroke
March 2025
Boston University School of Medicine, Medical Campus, Neurology Department, MA 02118, USA.
Background: Cerebral microbleeds (CMB) signal cerebral small vessel disease and are associated with ischemic stroke. While illicit drug use (IDU) is linked to cerebral vasculopathy, the association between CMB and IDU is poorly characterized.
Aims: Our primary aim was to explore the relationship between IDU and CMB and delineate differences in vascular risk factors between those with and without CMB.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!